CIK 0000818033 · Accelerated filer
HERON THERAPEUTICS, INC. /DE/
Sign in to watch- Ticker
- HRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 942875566
- Phone
- 8582514400
- Business address
- 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-13 | Szekeres David Leslie EVP, Chief Operating Officer | Shares withheld for taxes | −423 | $18.16 | $8K | 827 |
| 2021-01-13 | Szekeres David Leslie EVP, Chief Operating Officer | Option exercise · Restricted Stock Units | −1,250 | 18,750 | ||
| 2021-01-13 | Quart Barry D Chief Executive Officer | Option exercise | +3,646 | 92,872 | ||
| 2021-01-13 | Quart Barry D Chief Executive Officer | Shares withheld for taxes | −963 | $18.16 | $17K | 91,909 |
| 2021-01-13 | Quart Barry D Chief Executive Officer | Option exercise · Restricted Stock Units | −3,646 | 54,687 | ||
| 2021-01-13 | POYHONEN JOHN President & CCO | Option exercise | +1,250 | 20,030 | ||
| 2021-01-13 | POYHONEN JOHN President & CCO | Shares withheld for taxes | −433 | $18.16 | $8K | 19,597 |
| 2021-01-13 | POYHONEN JOHN President & CCO | Option exercise · Restricted Stock Units | −1,250 | 18,750 | ||
| 2021-01-13 | Peraza Lisa VP, Chief Accounting Officer | Option exercise | +552 | 11,811 | ||
| 2021-01-13 | Peraza Lisa VP, Chief Accounting Officer | Shares withheld for taxes | −227 | $18.16 | $4K | 11,584 |
| 2021-01-13 | Peraza Lisa VP, Chief Accounting Officer | Option exercise · Restricted Stock Units | −552 | 8,281 | ||
| 2021-01-13 | MANHARD KIMBERLY EVP, Drug Development | Option exercise | +1,250 | 1,250 | ||
| 2021-01-13 | MANHARD KIMBERLY EVP, Drug Development | Shares withheld for taxes | −433 | $18.16 | $8K | 817 |
| 2021-01-13 | MANHARD KIMBERLY EVP, Drug Development | Option exercise · Restricted Stock Units | −1,250 | 18,750 | ||
| 2016-11-04 | Quart Barry D Chief Executive Officer | Gift | −600 | 0 | ||
| 2016-11-04 | Quart Barry D Chief Executive Officer | Gift | +600 | 92,509 | ||
| 2015-06-20 | Quart Barry D Chief Executive Officer | Other acquisition | +600 | 600 |
Page 28 of 28 · 557 trades